London’s unicorns: City’s tech start-ups are bringing in the big bucks December 21, 2022 London’s tech start-ups have had a turbulent 2022. But while some of the original tech players in the city have struggled with rising costs and depleting revenues, newer unicorns are making moves. Here are the five London start-ups that made their mark this year, and are to be watched out for in 2023. OakNorth Valued [...]
Elon Musk’s year in Tweets: Ukraine, buying Twitter, Trump, Bitcoin and blue ticks December 21, 2022 Elon Musk’s time as Twitter CEO has been controversial. Even before his purchase of the social media platform, the business magnate and investor was an avid Twitter user. After a turbulent year online – and off – we have done the painstaking task of trawling through the Tesla billionaire’s feed, for high (and low) points [...]
Queensway, Notting Hill and Holland Park stations get 4G coverage December 21, 2022 Commuters travelling between Queensway and Holland Park will no longer have to worry about pausing their favourite Netflix show as the three Central line stations have begun supporting 4G and 5G coverage. Transport for London (TfL) has announced that three additional stations – Kentish Town, Tufnell Park and Archway on the Northern line – will [...]
Pharma firm makes RSV vaccine candidate breakthrough with artificial intelligence December 21, 2022 Biopharmaceutical firm Poolbeg Pharma has found a number of RSV vaccine candidates via artificial intelligence (AI), in a landmark move in finding a treatment for the virus. The London-listed company has prioritised candidates with existing early-stage clinical data, which could be repositioned into novel treatments for RSV infection. Candidates with solid safety data in humans [...]
Elon Musk vows to step down as Twitter CEO if someone ‘foolish enough’ accepts role December 21, 2022 Elon Musk has vowed to officially step down as the CEO of Twitter, once he finds someone “foolish enough” to accept the top role. The eccentric billionaire, who bought Twitter for $44bn (£36bn) in a protracted deal which was finalised in October, has helmed the social media giant after his controversial firing spree. But a [...]
Exclusive: Top fintechs slam regulators for slow progress on open banking December 20, 2022 A group of top fintech firms including Monzo and Wise have slammed UK regulators for a lack of progress on open banking today, claiming the “integrity and potential” of the regime in the UK is at risk.
Fortnite fined over £420m as video game makers face regulation December 20, 2022 Makers of videogame Fortnite have been fined a record $520m (£428m) by the US’s Federal Trade Commission (FTC). The fine is a two part penalty for Epic Games, the video game company behind Fortnite. The company was fined for tricking players into making in-game purchases and for storing children’s data without parental consent. The penalty [...]
Meta under fire may face £10m fine from EU December 20, 2022 Meta, Facebook’s parent company has been accused of flouting competition rules by an EU commission. If the charges are proven, they may face a penalty of up to £10m. Meta is likely in breach of the European Union’s anti-trust regulations. The EU’s preliminary review has found that Meta has tied access to the social media [...]
Tesla stock swings as Musk misbehaves December 20, 2022 Stock prices for Tesla have been unstable as CEO Elon Musk continues his streak of chaos on Twitter. Investors in Tesla have been critical of Musk’s new role in Twitter. His policies on the social media platform will backfire on the car brand, they claim. ““Customers don’t want their cars to be controversial. They want [...]
Drug developer files patents for cancer treatment which ‘outperforms’ AstraZeneca offering December 20, 2022 Drug development company Nuformix has reformulated and improved one of AstraZeneca’s top cancer drugs, piquing investor interest today. Shares in the London-listed firm jumped nearly a quarter to 35p per share by early afternoon on Tuesday. Nuformix, which focuses on fibrosis and cancer drug repurposing, announced that the drug, known as Olaparib, had “outperformed” AstraZeneca’s [...]